Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumihiko Kanai

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Saudi Medical Journal|May 29, 2007
Local ablation therapy for hepatocellular carcinoma. From ethanol injection to radiofrequency ablationShuichiro Shiina, Ryosuke Tateishi, Hideo Yoshida, et al.
European Journal of Radiology|November 3, 2012
Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imagingMasanori Takahashi, Hitoshi Maruyama, Taro Shimada, et al.
Ultrasound in Medicine & Biology|January 21, 2012
Heterogeneity of microbubble accumulation: a novel approach to discriminate between well-differentiated hepatocellular carcinomas and regenerative nodulesHitoshi Maruyama, Masanori Takahashi, Tadashi Sekimoto, et al.
AJR. American Journal of Roentgenology|February 26, 2013
Pretreatment microbubble-induced enhancement in hepatocellular carcinoma predicts intrahepatic distant recurrence after radiofrequency ablationHitoshi Maruyama, Masanori Takahashi, Taro Shimada, et al.
Hepatology International|July 24, 2015
Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinomaSadahisa Ogasawara, Fumihiko Kanai, Yoshihiko Ooka, et al.
Ultrasound in Medicine & Biology|October 3, 2012
Linear enhancement after radio-frequency ablation for hepatocellular carcinoma: is it a sign of recurrence?Masanori Takahashi, Hitoshi Maruyama, Taro Shimada, et al.
Biomed Research International|October 10, 2014
Partial splenic embolization with transarterial chemoembolization in patients with hepatocellular carcinoma accompanied by thrombocytopeniaYoshihiko Ooka, Tetsuhiro Chiba, Sadahisa Ogasawara, et al.
Journal of Biochemistry|February 16, 2007
Smad4 is essential for down-regulation of E-cadherin induced by TGF-beta in pancreatic cancer cell line PANC-1Shinichi Takano, Fumihiko Kanai, Amarsanaa Jazag, et al.
Scandinavian Journal of Gastroenterology|May 9, 2009
Quantification of hepatitis C amino acid substitutions 70 and 91 in the core coding region by real-time amplification refractory mutation system reverse transcription-polymerase chain reactionShingo Nakamoto, Tatsuo Kanda, Yutaka Yonemitsu, et al.
Journal of Gastroenterology and Hepatology|November 15, 2013
Natural history of postvascular-phase iso-enhanced lesions on the sonogram in chronic liver diseasesTakayuki Kondo, Hitoshi Maruyama, Tadashi Sekimoto, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Saudi Medical Journal|May 29, 2007
Local ablation therapy for hepatocellular carcinoma. From ethanol injection to radiofrequency ablationShuichiro Shiina, Ryosuke Tateishi, Hideo Yoshida, et al.
European Journal of Radiology|November 3, 2012
Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imagingMasanori Takahashi, Hitoshi Maruyama, Taro Shimada, et al.
Ultrasound in Medicine & Biology|January 21, 2012
Heterogeneity of microbubble accumulation: a novel approach to discriminate between well-differentiated hepatocellular carcinomas and regenerative nodulesHitoshi Maruyama, Masanori Takahashi, Tadashi Sekimoto, et al.
AJR. American Journal of Roentgenology|February 26, 2013
Pretreatment microbubble-induced enhancement in hepatocellular carcinoma predicts intrahepatic distant recurrence after radiofrequency ablationHitoshi Maruyama, Masanori Takahashi, Taro Shimada, et al.
Hepatology International|July 24, 2015
Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinomaSadahisa Ogasawara, Fumihiko Kanai, Yoshihiko Ooka, et al.
Ultrasound in Medicine & Biology|October 3, 2012
Linear enhancement after radio-frequency ablation for hepatocellular carcinoma: is it a sign of recurrence?Masanori Takahashi, Hitoshi Maruyama, Taro Shimada, et al.
Biomed Research International|October 10, 2014
Partial splenic embolization with transarterial chemoembolization in patients with hepatocellular carcinoma accompanied by thrombocytopeniaYoshihiko Ooka, Tetsuhiro Chiba, Sadahisa Ogasawara, et al.
Journal of Biochemistry|February 16, 2007
Smad4 is essential for down-regulation of E-cadherin induced by TGF-beta in pancreatic cancer cell line PANC-1Shinichi Takano, Fumihiko Kanai, Amarsanaa Jazag, et al.
Scandinavian Journal of Gastroenterology|May 9, 2009
Quantification of hepatitis C amino acid substitutions 70 and 91 in the core coding region by real-time amplification refractory mutation system reverse transcription-polymerase chain reactionShingo Nakamoto, Tatsuo Kanda, Yutaka Yonemitsu, et al.
Journal of Gastroenterology and Hepatology|November 15, 2013
Natural history of postvascular-phase iso-enhanced lesions on the sonogram in chronic liver diseasesTakayuki Kondo, Hitoshi Maruyama, Tadashi Sekimoto, et al.
Pageof 9